User banner image
User avatar
  • admin

Posts

Tung Oil Industry Research Report 2024 – Global Trends, Opportunities and Forecasts 2019-2029: Asia-Pacific’s Production and Consumption Capabilities Underscores their Dominant Position

Dublin, Nov. 14, 2024 (GLOBE NEWSWIRE) — The “Tung Oil Market – Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F” report has been added...

Championing Change: Celebrating Creativity and Tackling Violence in the Arts at the Parliamentary Society for Arts and Fashion Assembly 2024

House of Parliament – 24th October 2024 LONDON, Nov. 14, 2024 (GLOBE NEWSWIRE) —  Recently, on 24th October 2024, the Parliamentary Society for Arts and...

Polyethylene Glycol Market Estimated to Reach $5.31 billion by 2029 Globally, at a CAGR of 6.2%, says MarketsandMarkets™

Delray Beach, FL, Nov. 14, 2024 (GLOBE NEWSWIRE) — The Polyethylene Glycol Market is projected to grow from USD 3.94 billion in 2024 to USD 5.31...

Invivyd Announces New England Journal of Medicine Publishes Letter to the Editor Highlighting Immunobridging Pathway Leading to PEMGARDA™ (pemivibart) Emergency Use Authorization; Comments on Adjacent Third-Party Letter to the Editor

The New England Journal of Medicine (NEJM) Letter to the Editor outlines the novel, rapid immunobridging authorization pathway for PEMGARDA and provides an updated correlate...

GH Research Reports Third Quarter 2024 Financial Results and Provides Business Updates

Phase 2b clinical trial of GH001 in patients with treatment-resistant depression completed enrolment of the double-blind phase in Q3 2024 Phase 1 clinical trial to...

Rapport Therapeutics to Present Data at American Epilepsy Society Annual Meeting

Poster presentations on Phase 2a trial seizure biomarker, preclinical, and Phase 1 clinical data BOSTON and SAN DIEGO, Nov. 14, 2024 (GLOBE NEWSWIRE) — Rapport...

Skye Bioscience Surpasses 50% Patient Enrollment in Phase 2 Obesity Study of Differentiated CB1 Inhibitor

SAN DIEGO, Nov. 14, 2024 (GLOBE NEWSWIRE) — Skye Bioscience, Inc. (Nasdaq: SKYE) (“Skye”), a clinical-stage biopharmaceutical company focused on unlocking new therapeutic pathways for...

Achilles Therapeutics Reports Third Quarter 2024 Financial Results

– Cash position of $86.1 million as of September 30, 2024, not including cash R&D tax credit of $12.8 million received in October 2024 – ...

Sun Yat-sen University Successfully Hosts Global Forum of University Presidents

GUANGZHOU, China, Nov. 14, 2024 /PRNewswire/ — On November 11th, Global Forum of University Presidents was successfully held at the Guangzhou Campus of Sun Yat-sen...

ZainTECH and Tencent collaborate to introduce advanced Digital Twin applications regionally

Revolutionizing results and transforming knowledge into power for enterprises Digital Twins support the optimization of business operations, enhancement of decision-making processes, and driving of sustainable...